Track Varex Imaging Corporation — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Varex Imaging Corporation VREX Open Varex Imaging Corporation in new tab

10.50 USD
EPS
-1.64
P/B
0.92
ROE
-12.90
Beta
1.00
Target Price
18.40 USD
Varex Imaging Corporation logo

Varex Imaging Corporation

🧾 Earnings Recap – Q1 2026

Varex Imaging reported a strong start to FY 2026 with Q1 revenues of $210 million, reflecting a 5% year-over-year increase, driven primarily by robust performance in the Industrial segment.

  • Industrial segment revenue surged 17% year-over-year, supported by high demand in cargo systems and nondestructive testing applications.
  • Non-GAAP gross margin reached 34%, benefiting from a favorable product sales mix, aligning with guidance.
  • Non-GAAP EBITDA rose to $29 million, a 12% increase year-over-year, while Non-GAAP EPS improved to $0.19, up from $0.10.
  • Customer engagement at RSNA highlighted positive trends in demand, with increased focus on next-generation system designs and strong sales trends in certain medical modalities.
  • Varex's integrated modality-based approach to product offerings is expected to enhance customer partnerships and drive long-term revenue growth through system-level design wins.
📅
Loading chart...
Key Metrics
Earnings dateMay 14, 2026
EPS-1.64
Book Value11.38
Price to Book0.92
Debt/Equity81.76
% Insiders1.641%
Growth
Revenue Growth0.05%
Estimates
Forward P/E9.97
Forward EPS1.05
Target Mean Price18.40

DCF Valuation

Tweak assumptions to recompute fair value for Varex Imaging Corporation (VREX)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Varex Imaging Corporation Logo Varex Imaging Corporation Analysis (VREX)

United States Health Care Official Website Stock

Is Varex Imaging Corporation a good investment? Varex Imaging Corporation (VREX) is currently trading at 10.50 USD. Market analysts have a consensus price target of 18.40 USD. This suggests a potential upside from current levels.

Earnings Schedule: Varex Imaging Corporation is expected to release its next earnings report on May 14, 2026. The market consensus estimate for Forward EPS is 1.05.

Investor FAQ

Does Varex Imaging Corporation pay a dividend?

No, it does not currently pay a dividend.

What asset class is Varex Imaging Corporation?

Varex Imaging Corporation is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be May 14, 2026. The company currently has a trailing EPS of -1.64.

Company Profile

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. It operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. This segment's products are used in a range of applications, including CT, mammography, oncology, cardiac, surgery, dental, and other diagnostic radiography uses. The Industrial segment designs, develops, manufactures, sells, and services Linatron X-ray linear accelerators, non-intrusive cargo inspection systems, X-ray tubes, digital detectors, high voltage connectors, and coolers for use in security and inspection applications, such as baggage screening at airports, cargo screening at ports and borders, and nondestructive testing, irradiation, and inspection in various applications. It sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. The company has operations in North America, Latin America, Europe, the Middle East, India, Africa, Asia, and Australia. The company was incorporated in 2016 and is headquartered in Salt Lake City, Utah.

Exchange Ticker
NMS (United States) VREX

Dividends

Historical Split Corporate Actions

Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion